Logo for BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Investor Relations Material

Latest events

Logo for BioMarin Pharmaceutical Inc

M&A Announcement

BioMarin Pharmaceutical
Logo for BioMarin Pharmaceutical

M&A Announcement

16 May, 2025
Logo for BioMarin Pharmaceutical

Q1 2025

1 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from BioMarin Pharmaceutical Inc

Access all reports
BioMarin Pharmaceutical Inc is a biotechnology company focused on developing and commercializing therapies for rare genetic diseases. Its research and product development efforts target conditions with limited treatment options, primarily in the fields of enzyme replacement and gene therapy. The company serves healthcare providers and patients worldwide through approved treatments and scientific initiatives. The company is headquartered in San Rafael, California, and its shares are listed on the NASDAQ.